A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas
NCT02788916 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 198
Last updated 2017-03-21
Summary
The purpose of this study is to establish the distribution of peripheral T-cell lymphocyte (PTCL) subtypes by re-analysis and re-classification of samples according to the 2008 World Health Organization (WHO) classification of lymphoid neoplasms.
Conditions
- Lymphoma, T-Cell, Peripheral
Interventions
- OTHER
-
No Intervention
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Director Clinical Science · Takeda
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-25
- Primary Completion
- 2016-11-10
- Completion
- 2017-01-12
Countries
- Spain
Study Locations
More Related Trials
-
Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
NCT06588868 ·Status: RECRUITING
-
Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma
NCT00425555 ·Status: COMPLETED ·Phase: PHASE2
-
Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL
NCT05557903 ·Status: UNKNOWN ·Phase: PHASE1
-
Circulating Tumor DNA Sequencing in Patients With Peripheral T-cell Lymphomas
NCT06089941 ·Status: ACTIVE_NOT_RECRUITING
-
Prognostic Value of Clinical and Biological Factors in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma
NCT01369784 ·Status: COMPLETED
-
Italian Multicenter Retrospective Observational Study on Transformed Lymphomas
NCT02927756 ·Status: UNKNOWN
-
Identification Predictive Markers of Immunochemotherapy Response to the Primary Cutaneous Diffuse Large B Cell Lymphoma
NCT04183569 ·Status: UNKNOWN
-
Observational Controlled Clinical Trials, on Adult Patients With T-lymphoblastic Lymphoma Treated With Intensive Chemo/Radiotherapy or Intensive Chemotherapy Followed by Transplant. Evaluation of Clinical, Anatomy -Pathological Parameters
NCT00882011 ·Status: UNKNOWN
-
Study on Plasmablastic Lymphoma Patients
NCT06781359 ·Status: RECRUITING
-
Minimal Residual Disease in Peripheral T-cell Lymphoma
NCT03297697 ·Status: COMPLETED
-
A Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab Vedotin
NCT05886478 ·Status: COMPLETED
-
Phase II of Efficacy and Toxicity of Maintenance Sub. Rituximab After Induction in Relapsed MCL and Non-eligible HSCT
NCT02267915 ·Status: UNKNOWN ·Phase: PHASE2
-
T-cell Brazil: Prospective Collection of Data in T-cell Lymphomas Patients
NCT03207789 ·Status: UNKNOWN
-
Circulating Tumor DNA in Peripheral T-cell Lymphomas
NCT06362148 ·Status: ACTIVE_NOT_RECRUITING
-
TisaGenlecleucel in Elderly Patients With First-Relapsed or Primary Refractory Aggressive B-cell Non-Hodgkin Lymphoma
NCT04161118 ·Status: TERMINATED ·Phase: PHASE2
-
Identification of Prognostic Factors and New Therapeutic Targets in Cutaneous Lymphomas
NCT04520529 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Translational Study of Molecular Classification of Relapsed/Refractory Diffuse Large B-cell Lymphoma
NCT05318391 ·Status: COMPLETED
-
Correlation Analysis of T-lymphocyte Subsets and Prognosis in Autologous Stem Cell Transplantation (ASCT) for Lymphoma
NCT03283111 ·Status: UNKNOWN ·Phase: NA
-
Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
NCT01110733 ·Status: COMPLETED
-
Observational Study in Japanese Patients With Peripheral T-Cell Lymphoma Who Received Second-Line Therapy
NCT06422247 ·Status: COMPLETED
-
Mechanism of Resistance to GNC-038 in Relapsed and Refractory Diffuse Large B-cell Lymphoma
NCT05189782 ·Status: UNKNOWN
-
International Extranodal NK/T-cell Lymphoma Project
NCT02386813 ·Status: COMPLETED
-
Maintenance Therapy With Anti-PD-1 Antibody for Patients With NK/T-cell Lymphoma
NCT04338282 ·Status: UNKNOWN ·Phase: PHASE2
-
Transplantation After Complete Response In Patients With T-cell Lymphoma
NCT05444712 ·Status: RECRUITING ·Phase: NA
-
A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment
NCT01007292 ·Status: COMPLETED ·Phase: PHASE2